BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 26294067)

  • 41. [IgD myeloma: an aggressive variant. Description of a clinical case and review of the literature].
    Airoldi M; Pelucco L; Lamperti R; Gioia F
    Recenti Prog Med; 1993 Jun; 84(6):423-7. PubMed ID: 8516549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum free light chain analysis.
    Davids MS; Murali MR; Kuter DJ
    Am J Hematol; 2010 Oct; 85(10):787-90. PubMed ID: 20721885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
    Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
    Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgD-lambda myeloma with separate heavy- and light-chain M-components.
    Vilpo JA; Irjala K
    Clin Chem; 1980 Nov; 26(12):1760-1. PubMed ID: 6775847
    [No Abstract]   [Full Text] [Related]  

  • 48. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
    Pruzanski W; Rother I
    Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgD myeloma: immunology and ultrastructure.
    Ioachim NJ; McKenna PJ; Halperin I; Chung FJ
    Ann Clin Lab Sci; 1978; 8(3):209-18. PubMed ID: 418730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [IgD myeloma. Considerations about its diagnosis based on three cases (author's transl)].
    López-Aldeguer J; Redón J; González-Molina J; Benedito M; Herranz C; Lacruz J; Navarro JR; Caballero M
    Sangre (Barc); 1981; 26(6):1139-44. PubMed ID: 6805083
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literature.
    Tokunaga T; Hashimoto H; Yoshida Y; Sugimoto T; Mokuda S; Kosaka Y; Shimizu R; Hirata S; Kumagai T; Komoto K; Wada H; Sugiyama E
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):22-28. PubMed ID: 32985955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Free light chains assay: Indications and methods].
    Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
    Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How lab staff and the estimation of free light chains can combine to aid the diagnosis of light chain disease.
    Sinclair D; Wainwright L
    Clin Lab; 2007; 53(5-6):267-71. PubMed ID: 17605400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgD myeloma protein with "unreactive" light chain determinants.
    Cejka J; Kithier K
    Clin Chem; 1979 Aug; 25(8):1495-8. PubMed ID: 88283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
    Bladé J; Kyle RA
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloid arthropathy resembling seronegative rheumatoid arthritis in a patient with IgD-kappa multiple myeloma.
    Fujishima M; Komatsuda A; Imai H; Wakui H; Watanabe W; Sawada K
    Intern Med; 2003 Jan; 42(1):121-4. PubMed ID: 12583633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unusual myelomas: a review of IgD and IgE variants.
    Pandey S; Kyle RA
    Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammapathies.
    Fine JM; Lambin P
    Biomedicine; 1975 Oct; 23(8):323-7. PubMed ID: 821548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
    Chepovetsky J; Chari A; Jagannath S; Ramanthan L
    Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.